No Data
No Data
JACOBIO-B: (1) INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024;(2) RESIGNATION OF NON-EXECUTIVE DIRECTOR; AND(3) CHANGE IN THE COMPOSITION OF THE REMUNERATIONCOMMITTEE AND THE NOMINATION COMMITTEE
Express News | Inside Information - Jacobio Announces Exclusive Licensing-Out Agreement With Allist for Glecirasib and Jab-3312
JACOBIO-B: SUPPLEMENTAL ANNOUNCEMENTTO THE 2023 INTERIM REPORT AND THE 2023 ANNUAL REPORT
Jiakosi-B (01167.HK) plans to hold a board of directors meeting on August 30th to approve its interim performance.
Gelonghui August 20th | Kakosi-B (01167.HK) announced that the board of directors meeting will be held on Friday, August 30, 2024 to review and approve (including) the company and its subsidiaries performance for the six-month interim period ending on June 30, 2024 and its release, as well as deal with other matters.
JACOBIO-B: DATE OF BOARD MEETING
Jacobio Pharmaceuticals Doses 1st Patient in Phase 3 Trial of Lung Cancer Drug
No Data
No Data